Abclon Inc.

République de Corée

Commandez votre montre hebdomadaire Abclon Inc.
Quantité totale PI 34
Rang # Quantité totale PI 43 424
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 40 646
Symbole boursier 174900 (kosdaq)
ISIN KR7174900001
Capitalisation 235.2B  (KRW)

Brevets

Marques

11 0
5 0
18 0
0
 
Dernier brevet 2025 - Antibody or antigen-binding frag...
Premier brevet 2014 - Antibody specifically binding to...

Derniers inventions, produits et services

2024 Invention Anti-cd30 antibody and chimeric antigen receptor comprising thereof. Disclosed herein are a novel...
Invention Dual antigen-targeting protein complex comprising antibody or antigen-binding fragment thereof an...
2023 Invention Anti-cd30 antibody and chimeric antigen receptor comprising thereof. Disclosed herein are a nove...
Invention Antibody or antigen-binding fragment thereof that targets cotinine, chimeric antigen receptor com...
2022 Invention Affibody binding specifically to cd137 and use thereof. The present invention relates to: an affi...
Invention Antibody or antigen binding fragment thereof for specifically recognizing b cell malignancy, chim...
2021 Invention Anti-sars-cov-2 s protein antibody or antigen-binding fragment thereof, and pharmaceutical compos...
Invention Anti-her2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising ...
Invention Anti-her2 affibody and switchable chimeric antigen receptor using same as switch molecule. Disclo...
Invention Anti-her2 affibody, and switchable chimeric antigen receptor using same as switch molecule. The p...
2019 Invention Switch molecule and switchable chimeric antigen receptor. The present invention relates to a swit...
2018 Invention Antibody or antigen-binding fragment thereof that specifically recognizes b cell malignancies, ch...
Invention Polypeptide improved in protein purity and affinity for antigen, conjugate thereof with antibody ...
2017 Invention Novel myeloma cell for developing hybridoma. The present invention relates to a myeloma cell over...
Invention Antibody having improved stability and specifically binding to her2. The present invention replac...
2016 Invention Antibody specifically binding to cd80 and cd86. The present invention relates to a novel antibody...
Invention Antibodies against vascular endothelial growth factor receptor 2 (vegfr2), encoding nucleic acid ...
Invention Antibody specifically binding to vegfr2. The present invention relates to a novel VEGFR2 antibody...
2015 Invention Il-6-binding polypeptide complex. 29. The present disclosure also relates to the use of said comp...
Invention New polypeptide. The present disclosure relates to complex comprising an engineered polypeptide h...
2014 Invention Antibody specifically binding to her2. The present invention relates to HER2 (Human Epidermal Gro...
Invention Antibody specifically binding to her2. The present invention relates to a novel HER2 antibody for...